Suppr超能文献

一位住院医生对卵巢癌的看法。

A Resident's Perspective of Ovarian Cancer.

作者信息

Smith Christopher G

机构信息

Department of Obstetrics & Gynecology, University of Kentucky Medical Center, 800 Rose Street, Lexington, KY 40536-0293, USA.

出版信息

Diagnostics (Basel). 2017 Apr 27;7(2):24. doi: 10.3390/diagnostics7020024.

Abstract

Identifying, understanding, and curing disease is a lifelong endeavor for any medical practitioner. Equally as important is to be cognizant of the impact a disease has on the individual suffering from it, as well as on their family. Ovarian cancer is the leading cause of death from gynecologic malignancies. Symptoms are vague, and the disease is generally at an advanced stage at diagnosis. Efforts have been made to develop methods to identify ovarian cancer at earlier stages, thus improving overall mortality. Transvaginal ultrasound (TVUS), with and without laboratory tests, can be used to screen for ovarian cancer. For over thirty years, the University of Kentucky Markey Cancer Center Ovarian Cancer Screening Program has been studying the efficacy of TVUS for detecting early stage ovarian cancer. After 285,000+ TVUS examinations provided to over 45,000 women, the program has demonstrated that regular TVUS examinations can detect ovarian cancer at early stages, and that survival is increased in those women whose ovarian cancer was detected with screening and who undergo standard treatment. These results demonstrate the utility of TVUS as an efficacious method of ovarian cancer screening.

摘要

对于任何医学从业者来说,识别、理解和治愈疾病都是一项终身的事业。同样重要的是,要认识到疾病对患病个体及其家庭的影响。卵巢癌是妇科恶性肿瘤的主要死因。症状不明确,疾病在诊断时通常已处于晚期。人们一直在努力开发在早期阶段识别卵巢癌的方法,从而提高总体死亡率。经阴道超声检查(TVUS),无论是否结合实验室检查,都可用于筛查卵巢癌。三十多年来,肯塔基大学马基癌症中心卵巢癌筛查项目一直在研究TVUS检测早期卵巢癌的功效。在为超过45000名女性提供了285000多次TVUS检查后,该项目证明定期TVUS检查可以在早期阶段检测出卵巢癌,并且那些通过筛查检测出卵巢癌并接受标准治疗的女性的生存率有所提高。这些结果证明了TVUS作为一种有效的卵巢癌筛查方法的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab9/5489944/e993f46443fd/diagnostics-07-00024-g001.jpg

相似文献

1
A Resident's Perspective of Ovarian Cancer.
Diagnostics (Basel). 2017 Apr 27;7(2):24. doi: 10.3390/diagnostics7020024.
2
Direct access from general practice to transvaginal ultrasound for early detection of ovarian cancer: a feasibility study.
Scand J Prim Health Care. 2021 Jun;39(2):230-239. doi: 10.1080/02813432.2021.1922831. Epub 2021 Jun 7.
8
Understanding Patient Preference in Female Pelvic Imaging: Transvaginal Ultrasound and MRI.
Acad Radiol. 2018 Apr;25(4):439-444. doi: 10.1016/j.acra.2017.10.011. Epub 2017 Dec 11.

引用本文的文献

1
The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms.
Front Pharmacol. 2023 Mar 16;14:1156629. doi: 10.3389/fphar.2023.1156629. eCollection 2023.
2
Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer.
Cureus. 2022 Oct 21;14(10):e30561. doi: 10.7759/cureus.30561. eCollection 2022 Oct.
3
Dysregulation of lncRNA-miRNA-mRNA Interactome as a Marker of Metastatic Process in Ovarian Cancer.
Biomedicines. 2022 Mar 31;10(4):824. doi: 10.3390/biomedicines10040824.
4
Identification of the Mutational Landscape of Gynecological Malignancies.
J Cancer. 2020 Jun 8;11(16):4870-4883. doi: 10.7150/jca.46174. eCollection 2020.
5
Ovarian Cancer Screening: Lessons about Effectiveness.
Diagnostics (Basel). 2017 Dec 29;8(1):1. doi: 10.3390/diagnostics8010001.
6
Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
Gynecol Oncol Rep. 2017 Jun 15;21:37-44. doi: 10.1016/j.gore.2017.06.006. eCollection 2017 Aug.

本文引用的文献

1
Serous Tubal Intraepithelial Carcinoma Associated With Extraovarian Metastases.
Int J Gynecol Cancer. 2017 Mar;27(3):444-451. doi: 10.1097/IGC.0000000000000920.
2
The disparate origins of ovarian cancers: pathogenesis and prevention strategies.
Nat Rev Cancer. 2017 Jan;17(1):65-74. doi: 10.1038/nrc.2016.113. Epub 2016 Nov 25.
3
Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies.
Anticancer Res. 2016 Oct;36(10):5031-5042. doi: 10.21873/anticanres.11072.
4
Epidemiology of epithelial ovarian cancer.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:3-14. doi: 10.1016/j.bpobgyn.2016.08.006. Epub 2016 Oct 3.
5
Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.
Gynecol Oncol. 2016 Nov;143(2):270-275. doi: 10.1016/j.ygyno.2016.08.334. Epub 2016 Sep 9.
7
Current clinical application of serum biomarkers to detect ovarian cancer.
Prz Menopauzalny. 2015 Dec;14(4):254-9. doi: 10.5114/pm.2015.55887. Epub 2015 Nov 27.
8
Cancer statistics, 2016.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
9
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
10
Diagnosis of ovarian cancer.
BMJ. 2015 Sep 1;351:h4443. doi: 10.1136/bmj.h4443.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验